You are here

Yagyu Hiroaki

Researcher's full information

Articles
  • Identification of human ELOVL5 enhancer regions controlled by SREBP.
    Shikama A; Shinozaki H; Takeuchi Y; Matsuzaka T; Aita Y; ...
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS/465(4)/pp.857-863, 2015-08
  • Absence of Nceh1 augments 25-hydroxycholesterol-induced ER stress and apoptosis in macrophages.
    Sekiya Motohiro; Yamamuro Daisuke; Ohshiro Taichi; Honda ...
    J Lipid Res, 2014-12
  • Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitus.
    Okada Kenta; Kotani Kazuhiko; Yagyu Hiroaki; Ishibashi Shun
    Diabetol Metab Syndr/6(1)/p.85, 2014-8
  • Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
    Okada Kenta; Kotani Kazuhiko; Yagyu Hiroaki; Ando Akihiko...
    ENDOCRINE/47(3)/pp.962-964, 2014-12
  • Improved Glycemic Control with Naproxen for Inflammation in a Patient with Diabetes Caused by Interleukin-6-producing Pheochromocytoma
    古川祥子; 藤原和哉; 尾本美代子; 村山友樹; 呉 龍梅; 笹木...
    Journal of the Japan Diabetes Society/57(12)/pp.913-920, 2014-12
  • Body Weight Change and Type 2 Diabetes
    Kodama Satoru; Horikawa Chika; Yoshizawa Sakiko; Fujihara...
    EPIDEMIOLOGY/24(5)/pp.778-779, 2013-09
  • Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology
    Garcia-Arcos I; Hiyama Y; Drosatos K; Bharadwaj KG; Hu Y;...
    J Biol Chem/288(20)/pp.14046-14058, 2013-05
  • Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.
    Takahashi M; Yagyu Hiroaki; Tazoe F; Nagashima S; Ohshiro...
    J Lipid Res/54(4)/pp.1124-1134, 2013-04
  • Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus.
    Okada K; Yagyu H; Kotani K; Yamazaki H; Ozaki K; Takahash...
    Endocr J/60(7)/pp.913-922, 2013-4
  • Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitus
    Yagyu Hiroaki; Nagashima S; Takahashi M; Miyamoto M; Okad...
    Endocr J/59(12)/pp.1077-1084, 2012-12
  • Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional study
    Okada Kenta; Osuga Jun-ichi; Kotani Kazuhiko; Yagyu Hiroa...
    Tob Induc Dis/10/p.12, 2012-08
  • Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabets mellitus
    Yagyu H; Okada K; Sato S; Yamashita Y; Okada N; Osuga JI;...
    Diabetes Res Clin Pract/95(3)/pp.e52-e54, 2012-3
  • Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death
    Nagashima S; Yagyu H; Ohashi K; Fumiko Tazoe F; Takahashi...
    Arterioscler Thromb Vasc Biol/32/p.1824-31, 2012
  • Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
    Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu Hiroak...
    Arterioscler Thromb Vasc Biol/31/pp.1108-1115, 2011-5
  • Mollecular analysis of a novel LCAT mutation (Gly179→Arg) found in a patient with complete LCAT deficiency
    Wang XL; Osuga J; Tazoe F; Okada K; Nagashima S; Takahash...
    J Atheroscler Thromb/18(8)/pp.713-719, 2011-5
  • Depot-specific expression of lipolytic genes in human adipose tissues--association among CES1 expression, triglyceride lipase activity and adiposity.
    Nagashima S; Yagyu H; Takahashi N; Kurashina T; Takahashi...
    J Atheroscler Thromb/18/p.190-9, 2011
  • Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus
    Okada K; Yagyu H; Kotani K; Miyamoto M; Osuga J; Nagasaka...
    Endocr J/57/p.903-8, 2010
  • Induction of ABCA1 by overexpression of hormone-sensitive lipase in macrophages
    Tazoe Fumiko; Yagyu H; Okazaki Hiroaki; Igarashi Masaki; ...
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS/376(1)/pp.111-115, 2008-11
  • Cholesterol reduction and atherosclerosis of inhibition by bezafibrate in low density lipoprotein receptor knockout mice
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashim...
    Hypertens Res/31/p.999-1005, 2008
  • Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression.
    Augustus A; Yagyu H; Haemmerle G; Bensadoun A; Vikramadit...
    J Biol Chem/279/p.25050-7, 2004
  • Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.
    Yokoyama M; Yagyu H; Hu Y; Seo T; Hirata K; Homma S; Gold...
    J Biol Chem/279/p.Nov-04, 2004
  • Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy
    Yagyu H; Chen G; Yokoyama M; Hirata K; Augustus A; Kako Y...
    J Clin Invest/111/p.419-26, 2003
  • Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency
    Yagyu H; Lutz EP; Kako Y; Marks S; Hu Y; Choi SY; Bensado...
    J Biol Chem/277/p.10037-43, 2002
  • Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia.(jointly worked)
    Yagyu H; Kitamine T; Osuga J; Tozawa R; Chen Z; Kaji Y; O...
    J Biol Chem./275(28)/p.21324-21330, 2000-01
  • Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice.
    Yagyu H; Ishibashi S; Chen Z; Osuga J; Okazaki M; Perrey ...
    J Lipid Res/40(9)/p.1677-1685, 1999